vasculature while limiting damage to healthy tissue. Zahav Bioscience advances a clinical-stage pipeline that integrates chemistry, manufacturing and controls, bioconjugation chemistry, process development, and preclinical in vitro and in vivo models. The organization concentrates on translating structural concepts in nanomedicine into oncology drug candidates ready for clinical evaluation.